JP2019515672A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019515672A5 JP2019515672A5 JP2018554677A JP2018554677A JP2019515672A5 JP 2019515672 A5 JP2019515672 A5 JP 2019515672A5 JP 2018554677 A JP2018554677 A JP 2018554677A JP 2018554677 A JP2018554677 A JP 2018554677A JP 2019515672 A5 JP2019515672 A5 JP 2019515672A5
- Authority
- JP
- Japan
- Prior art keywords
- host cell
- amino acid
- acid sequence
- seq
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims description 94
- 102000037865 fusion proteins Human genes 0.000 claims description 66
- 108020001507 fusion proteins Proteins 0.000 claims description 66
- 230000027455 binding Effects 0.000 claims description 34
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 27
- 230000004068 intracellular signaling Effects 0.000 claims description 27
- 102000004127 Cytokines Human genes 0.000 claims description 26
- 108090000695 Cytokines Proteins 0.000 claims description 26
- 206010028980 Neoplasm Diseases 0.000 claims description 24
- 108091008874 T cell receptors Proteins 0.000 claims description 23
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 23
- 230000003834 intracellular effect Effects 0.000 claims description 20
- 102000039446 nucleic acids Human genes 0.000 claims description 19
- 108020004707 nucleic acids Proteins 0.000 claims description 19
- 150000007523 nucleic acids Chemical class 0.000 claims description 19
- 239000000427 antigen Substances 0.000 claims description 18
- 108091007433 antigens Proteins 0.000 claims description 18
- 102000036639 antigens Human genes 0.000 claims description 18
- 102000025171 antigen binding proteins Human genes 0.000 claims description 16
- 108091000831 antigen binding proteins Proteins 0.000 claims description 16
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 15
- 102100028113 Granulocyte-macrophage colony-stimulating factor receptor subunit alpha Human genes 0.000 claims description 15
- 101000916625 Homo sapiens Granulocyte-macrophage colony-stimulating factor receptor subunit alpha Proteins 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 claims description 14
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 12
- 201000011510 cancer Diseases 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims description 10
- 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 claims description 10
- -1 IL-2RA Proteins 0.000 claims description 10
- 102100029215 Signaling lymphocytic activation molecule Human genes 0.000 claims description 10
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims description 10
- 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 claims description 10
- 102100036305 C-C chemokine receptor type 8 Human genes 0.000 claims description 9
- 102100028989 C-X-C chemokine receptor type 2 Human genes 0.000 claims description 9
- 102100039622 Granulocyte colony-stimulating factor receptor Human genes 0.000 claims description 9
- 101000716063 Homo sapiens C-C chemokine receptor type 8 Proteins 0.000 claims description 9
- 101000746364 Homo sapiens Granulocyte colony-stimulating factor receptor Proteins 0.000 claims description 9
- 101000916644 Homo sapiens Macrophage colony-stimulating factor 1 receptor Proteins 0.000 claims description 9
- 108010018951 Interleukin-8B Receptors Proteins 0.000 claims description 9
- 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 claims description 9
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims description 9
- 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims description 8
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims description 8
- 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 claims description 8
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims description 8
- 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims description 8
- 102000017578 LAG3 Human genes 0.000 claims description 8
- 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims description 8
- 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 claims description 8
- 108040002099 interleukin-21 receptor activity proteins Proteins 0.000 claims description 8
- 102000008640 interleukin-21 receptor activity proteins Human genes 0.000 claims description 8
- 108040006861 interleukin-7 receptor activity proteins Proteins 0.000 claims description 8
- 230000031146 intracellular signal transduction Effects 0.000 claims description 8
- 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 claims description 7
- 101001103033 Homo sapiens Tyrosine-protein kinase transmembrane receptor ROR2 Proteins 0.000 claims description 7
- 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 claims description 7
- 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 claims description 7
- 102100040678 Programmed cell death protein 1 Human genes 0.000 claims description 7
- 102100039616 Tyrosine-protein kinase transmembrane receptor ROR2 Human genes 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 108040006849 interleukin-2 receptor activity proteins Proteins 0.000 claims description 7
- 102100027207 CD27 antigen Human genes 0.000 claims description 6
- 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims description 6
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims description 6
- 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 claims description 6
- 102100026244 Interleukin-9 receptor Human genes 0.000 claims description 6
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims description 6
- 108040006852 interleukin-4 receptor activity proteins Proteins 0.000 claims description 6
- 108040006862 interleukin-9 receptor activity proteins Proteins 0.000 claims description 6
- 230000004083 survival effect Effects 0.000 claims description 6
- 102100027205 B-cell antigen receptor complex-associated protein alpha chain Human genes 0.000 claims description 5
- 102100027203 B-cell antigen receptor complex-associated protein beta chain Human genes 0.000 claims description 5
- 101150013553 CD40 gene Proteins 0.000 claims description 5
- 102100039061 Cytokine receptor common subunit beta Human genes 0.000 claims description 5
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims description 5
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 5
- 102100029360 Hematopoietic cell signal transducer Human genes 0.000 claims description 5
- 101000914489 Homo sapiens B-cell antigen receptor complex-associated protein alpha chain Proteins 0.000 claims description 5
- 101000914491 Homo sapiens B-cell antigen receptor complex-associated protein beta chain Proteins 0.000 claims description 5
- 101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 claims description 5
- 101000990188 Homo sapiens Hematopoietic cell signal transducer Proteins 0.000 claims description 5
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims description 5
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims description 5
- 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 claims description 5
- 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 claims description 5
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 claims description 5
- 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 claims description 5
- 102000007497 Patched-2 Receptor Human genes 0.000 claims description 5
- 108010071083 Patched-2 Receptor Proteins 0.000 claims description 5
- 108010074687 Signaling Lymphocytic Activation Molecule Family Member 1 Proteins 0.000 claims description 5
- 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 claims description 5
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 5
- 108040002039 interleukin-15 receptor activity proteins Proteins 0.000 claims description 5
- 102000008616 interleukin-15 receptor activity proteins Human genes 0.000 claims description 5
- 108010074708 B7-H1 Antigen Proteins 0.000 claims description 4
- 102100039398 C-X-C motif chemokine 2 Human genes 0.000 claims description 4
- 102100021396 Cell surface glycoprotein CD200 receptor 1 Human genes 0.000 claims description 4
- 102100031351 Galectin-9 Human genes 0.000 claims description 4
- 101100229077 Gallus gallus GAL9 gene Proteins 0.000 claims description 4
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims description 4
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims description 4
- 102100034221 Growth-regulated alpha protein Human genes 0.000 claims description 4
- 101000889128 Homo sapiens C-X-C motif chemokine 2 Proteins 0.000 claims description 4
- 101000969553 Homo sapiens Cell surface glycoprotein CD200 receptor 1 Proteins 0.000 claims description 4
- 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 claims description 4
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims description 4
- 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 claims description 4
- 101000621309 Homo sapiens Wilms tumor protein Proteins 0.000 claims description 4
- 101710154942 Interleukin-2 receptor subunit beta Proteins 0.000 claims description 4
- 102100026879 Interleukin-2 receptor subunit beta Human genes 0.000 claims description 4
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 4
- 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 claims description 4
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 claims description 4
- 101100268066 Mus musculus Zap70 gene Proteins 0.000 claims description 4
- 102100025237 T-cell surface antigen CD2 Human genes 0.000 claims description 4
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims description 4
- 102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 claims description 4
- 102100022748 Wilms tumor protein Human genes 0.000 claims description 4
- 230000004044 response Effects 0.000 claims description 4
- 102000008160 Cyclin A1 Human genes 0.000 claims description 3
- 108010060267 Cyclin A1 Proteins 0.000 claims description 3
- 101710189311 Cytokine receptor common subunit gamma Proteins 0.000 claims description 3
- 102100026234 Cytokine receptor common subunit gamma Human genes 0.000 claims description 3
- 101001047640 Homo sapiens Linker for activation of T-cells family member 1 Proteins 0.000 claims description 3
- 101001038037 Homo sapiens Lysophosphatidic acid receptor 5 Proteins 0.000 claims description 3
- 102100040404 Lysophosphatidic acid receptor 5 Human genes 0.000 claims description 3
- 102000003735 Mesothelin Human genes 0.000 claims description 3
- 108090000015 Mesothelin Proteins 0.000 claims description 3
- 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 claims description 3
- 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 claims description 3
- 108010023649 Tripartite Motif Proteins Proteins 0.000 claims description 3
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims description 3
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 claims description 2
- 206010006187 Breast cancer Diseases 0.000 claims description 2
- 208000026310 Breast neoplasm Diseases 0.000 claims description 2
- 102100020789 Interleukin-15 receptor subunit alpha Human genes 0.000 claims description 2
- 101710107699 Interleukin-15 receptor subunit alpha Proteins 0.000 claims description 2
- 102100039078 Interleukin-4 receptor subunit alpha Human genes 0.000 claims description 2
- 101710169536 Interleukin-4 receptor subunit alpha Proteins 0.000 claims description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 2
- 206010033128 Ovarian cancer Diseases 0.000 claims description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 2
- 208000003721 Triple Negative Breast Neoplasms Diseases 0.000 claims description 2
- 208000009956 adenocarcinoma Diseases 0.000 claims description 2
- 208000002458 carcinoid tumor Diseases 0.000 claims description 2
- 230000003013 cytotoxicity Effects 0.000 claims description 2
- 231100000135 cytotoxicity Toxicity 0.000 claims description 2
- 239000000833 heterodimer Substances 0.000 claims description 2
- 201000005249 lung adenocarcinoma Diseases 0.000 claims description 2
- 201000005202 lung cancer Diseases 0.000 claims description 2
- 208000020816 lung neoplasm Diseases 0.000 claims description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 2
- 201000002528 pancreatic cancer Diseases 0.000 claims description 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 2
- 230000028327 secretion Effects 0.000 claims description 2
- 208000000649 small cell carcinoma Diseases 0.000 claims description 2
- 206010041823 squamous cell carcinoma Diseases 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 claims description 2
- 208000022679 triple-negative breast carcinoma Diseases 0.000 claims description 2
- 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 claims 3
- 101000863873 Homo sapiens Tyrosine-protein phosphatase non-receptor type substrate 1 Proteins 0.000 claims 3
- 102100029948 Tyrosine-protein phosphatase non-receptor type substrate 1 Human genes 0.000 claims 3
- 208000025205 Mantle-Cell Lymphoma Diseases 0.000 claims 2
- 101100451400 Mus musculus Hapln3 gene Proteins 0.000 claims 2
- 101100455223 Oryza sativa subsp. japonica LPR3 gene Proteins 0.000 claims 2
- 102000011408 Tripartite Motif Proteins Human genes 0.000 claims 2
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims 1
- 101100511506 Bombyx mori LP3 gene Proteins 0.000 claims 1
- 101001039256 Caenorhabditis elegans Low-density lipoprotein receptor-related protein Proteins 0.000 claims 1
- 101100503636 Danio rerio fyna gene Proteins 0.000 claims 1
- 101150018272 FYN gene Proteins 0.000 claims 1
- 101000694288 Homo sapiens 40S ribosomal protein SA Proteins 0.000 claims 1
- 101001055227 Homo sapiens Cytokine receptor common subunit gamma Proteins 0.000 claims 1
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 claims 1
- 101001030069 Homo sapiens Major vault protein Proteins 0.000 claims 1
- 101001043564 Homo sapiens Prolow-density lipoprotein receptor-related protein 1 Proteins 0.000 claims 1
- 101000702132 Homo sapiens Protein spinster homolog 1 Proteins 0.000 claims 1
- 101000738769 Homo sapiens Receptor-type tyrosine-protein phosphatase alpha Proteins 0.000 claims 1
- 108010043610 KIR Receptors Proteins 0.000 claims 1
- 101150028321 Lck gene Proteins 0.000 claims 1
- 102100024032 Linker for activation of T-cells family member 1 Human genes 0.000 claims 1
- 102000001759 Notch1 Receptor Human genes 0.000 claims 1
- 108010029755 Notch1 Receptor Proteins 0.000 claims 1
- 102000001756 Notch2 Receptor Human genes 0.000 claims 1
- 108010029751 Notch2 Receptor Proteins 0.000 claims 1
- 102000001760 Notch3 Receptor Human genes 0.000 claims 1
- 108010029756 Notch3 Receptor Proteins 0.000 claims 1
- 102000001753 Notch4 Receptor Human genes 0.000 claims 1
- 108010029741 Notch4 Receptor Proteins 0.000 claims 1
- 102100021923 Prolow-density lipoprotein receptor-related protein 1 Human genes 0.000 claims 1
- 101001038499 Yarrowia lipolytica (strain CLIB 122 / E 150) Lysine acetyltransferase Proteins 0.000 claims 1
- 238000010276 construction Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000019691 hematopoietic and lymphoid cell neoplasm Diseases 0.000 claims 1
- 102000046157 human CSF2 Human genes 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000019491 signal transduction Effects 0.000 claims 1
- 230000009870 specific binding Effects 0.000 claims 1
- 239000013598 vector Substances 0.000 description 13
- 230000011664 signaling Effects 0.000 description 11
- 230000000139 costimulatory effect Effects 0.000 description 8
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 102000040430 polynucleotide Human genes 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- 239000013603 viral vector Substances 0.000 description 3
- 102000006306 Antigen Receptors Human genes 0.000 description 2
- 108010083359 Antigen Receptors Proteins 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 102100029453 T-cell receptor-associated transmembrane adapter 1 Human genes 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 102100024965 Caspase recruitment domain-containing protein 11 Human genes 0.000 description 1
- 101000761179 Homo sapiens Caspase recruitment domain-containing protein 11 Proteins 0.000 description 1
- 101000868279 Homo sapiens Leukocyte surface antigen CD47 Proteins 0.000 description 1
- 101000634846 Homo sapiens T-cell receptor-associated transmembrane adapter 1 Proteins 0.000 description 1
- 101000809875 Homo sapiens TYRO protein tyrosine kinase-binding protein Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 102100032913 Leukocyte surface antigen CD47 Human genes 0.000 description 1
- 102100038717 TYRO protein tyrosine kinase-binding protein Human genes 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022139098A JP2022164858A (ja) | 2016-04-20 | 2022-09-01 | 免疫調整性ｉｌ２ｒ融合タンパク質およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662325428P | 2016-04-20 | 2016-04-20 | |
| US62/325,428 | 2016-04-20 | ||
| PCT/US2017/028693 WO2017184901A1 (en) | 2016-04-20 | 2017-04-20 | Immunomodulatory il2r fusion proteins and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022139098A Division JP2022164858A (ja) | 2016-04-20 | 2022-09-01 | 免疫調整性ｉｌ２ｒ融合タンパク質およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019515672A JP2019515672A (ja) | 2019-06-13 |
| JP2019515672A5 true JP2019515672A5 (enExample) | 2020-05-28 |
| JP7198670B2 JP7198670B2 (ja) | 2023-01-04 |
Family
ID=58710057
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018554677A Active JP7198670B2 (ja) | 2016-04-20 | 2017-04-20 | 免疫調整性ｉｌ２ｒ融合タンパク質およびその使用 |
| JP2022139098A Ceased JP2022164858A (ja) | 2016-04-20 | 2022-09-01 | 免疫調整性ｉｌ２ｒ融合タンパク質およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022139098A Ceased JP2022164858A (ja) | 2016-04-20 | 2022-09-01 | 免疫調整性ｉｌ２ｒ融合タンパク質およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20190127435A1 (enExample) |
| EP (1) | EP3445847B1 (enExample) |
| JP (2) | JP7198670B2 (enExample) |
| CN (1) | CN109312304A (enExample) |
| CA (1) | CA3021455A1 (enExample) |
| ES (1) | ES2981274T3 (enExample) |
| WO (1) | WO2017184901A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY196588A (en) * | 2015-03-05 | 2023-04-19 | Hutchinson Fred Cancer Res | Immunomodulatory Fusion Proteins and uses Thereof |
| US12202856B2 (en) * | 2016-05-19 | 2025-01-21 | The General Hospital Corporation | Tethered interleukin-2 to its receptor IL-2RBETA, a platform to enhance natural killer and regulatory T cell activity |
| CN110621335B (zh) | 2017-03-17 | 2025-06-03 | 弗雷德哈钦森癌症中心 | 免疫调节融合蛋白及其用途 |
| CN109503715B (zh) * | 2017-09-15 | 2023-12-15 | 科济生物医药（上海）有限公司 | Il-4r的融合蛋白及其应用 |
| CN108504685A (zh) * | 2018-03-27 | 2018-09-07 | 宜明细胞生物科技有限公司 | 一种利用CRISPR/Cas9系统同源重组修复IL-2RG缺陷基因的方法 |
| CN110615843B (zh) * | 2018-06-20 | 2023-05-09 | 上海隆耀生物科技有限公司 | 一种包含第三信号受体的嵌合抗原受体及其应用 |
| CA3097443A1 (en) * | 2018-11-12 | 2020-05-22 | I-Mab Biopharma Us Limited | Fusion proteins containing cd47 antibodies and cytokines |
| CA3144549A1 (en) * | 2019-06-28 | 2020-12-30 | Cafa Therapeutics Limited | Cell for resisting transplant reaction and method |
| CN114945375A (zh) * | 2019-09-11 | 2022-08-26 | 小利兰·斯坦福大学托管委员会 | 嵌合正交受体蛋白和使用方法 |
| US20220401537A1 (en) * | 2019-09-16 | 2022-12-22 | Fred Hutchinson Cancer Research Center | Chimeric receptor proteins and uses thereof |
| GB201913697D0 (en) * | 2019-09-23 | 2019-11-06 | King S College London | DAP10/DAP12 fusion polypeptides |
| MX2022003885A (es) * | 2019-10-08 | 2022-07-13 | Provincial Health Services Authority | Receptores quimericos de citoquinas. |
| WO2021141986A1 (en) * | 2020-01-07 | 2021-07-15 | St. Jude Children's Research Hospital, Inc. | Chimeric gmcsf-il18 receptor |
| CN113249330A (zh) * | 2021-05-20 | 2021-08-13 | 深圳市先康达生命科学有限公司 | 免疫细胞及其应用 |
| CA3235607A1 (en) * | 2021-11-02 | 2023-05-11 | Soheil MESHINCHI | Treatments for cancers utilizing cell-targeted therapies and associated research protocols |
| WO2024186656A1 (en) | 2023-03-03 | 2024-09-12 | Arsenal Biosciences, Inc. | Systems targeting psma and ca9 |
| WO2025039159A1 (en) * | 2023-08-21 | 2025-02-27 | Hangzhou Hervor Therapeutics Co., Ltd | Synthetic cytokine signaling system, preparation method, and uses thereof |
| WO2025081123A1 (en) | 2023-10-12 | 2025-04-17 | Fred Hutchinson Cancer Center | Methods and compositions for improving t cell immunotherapy |
| WO2025085536A1 (en) * | 2023-10-16 | 2025-04-24 | Lankenau Institute For Medical Research | Biologic conjugates that inhibit production of inflammatory cells and methods of use |
| CN117511885B (zh) * | 2024-01-08 | 2024-06-11 | 青岛华赛伯曼医学细胞生物有限公司 | 提高识别和杀伤肿瘤能力的工程化til细胞及其应用 |
| WO2025245169A1 (en) | 2024-05-21 | 2025-11-27 | Fred Hutchinson Cancer Center | Immunotherapy cells equipped with a collagen-targeting payload |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| AU695869B2 (en) * | 1993-04-06 | 1998-08-27 | Fred Hutchinson Cancer Research Center | Chimeric cytokine receptors in lymphocytes |
| CN101684158A (zh) * | 2001-01-17 | 2010-03-31 | 特鲁比昂药品公司 | 结合域-免疫球蛋白融合蛋白 |
| WO2008042814A2 (en) | 2006-09-29 | 2008-04-10 | California Institute Of Technology | Mart-1 t cell receptors |
| US9272002B2 (en) * | 2011-10-28 | 2016-03-01 | The Trustees Of The University Of Pennsylvania | Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting |
| EP2814846B1 (en) | 2012-02-13 | 2020-01-08 | Seattle Children's Hospital d/b/a Seattle Children's Research Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
| JP6578271B2 (ja) * | 2013-04-17 | 2019-09-18 | ベイラー カレッジ オブ メディスンＢａｙｌｏｒ Ｃｏｌｌｅｇｅ Ｏｆ Ｍｅｄｉｃｉｎｅ | 免疫抑制ＴＧＦ−βシグナルコンバーター |
-
2017
- 2017-04-20 CN CN201780037786.6A patent/CN109312304A/zh active Pending
- 2017-04-20 CA CA3021455A patent/CA3021455A1/en active Pending
- 2017-04-20 EP EP17724147.8A patent/EP3445847B1/en active Active
- 2017-04-20 JP JP2018554677A patent/JP7198670B2/ja active Active
- 2017-04-20 ES ES17724147T patent/ES2981274T3/es active Active
- 2017-04-20 US US16/094,420 patent/US20190127435A1/en not_active Abandoned
- 2017-04-20 WO PCT/US2017/028693 patent/WO2017184901A1/en not_active Ceased
-
2022
- 2022-09-01 JP JP2022139098A patent/JP2022164858A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019515672A5 (enExample) | ||
| JP2020114264A5 (enExample) | ||
| JP2022113880A5 (enExample) | ||
| JP2020511136A5 (enExample) | ||
| Weinkove et al. | Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations | |
| JP7198670B2 (ja) | 免疫調整性ｉｌ２ｒ融合タンパク質およびその使用 | |
| US10822392B2 (en) | Nucleic acids comprising polynucleotides encoding chimeric antigen receptors | |
| Salter et al. | Chimeric antigen receptor–modified T cells: CD19 and the road beyond | |
| AU2025205077A1 (en) | Methods for enhancing efficacy of therapeutic immune cells | |
| JP2021177771A5 (enExample) | ||
| US20240425565A1 (en) | Chimeric Natural Killer Cell Receptors and Method of Using Thereof | |
| CN108884164B (zh) | 用于免疫疗法的经修饰细胞 | |
| FI4324851T3 (fi) | BCMA-spesifisiä kimeerisiä antigeenireseptoreita ja niiden käyttöjä | |
| JP2020513754A5 (enExample) | ||
| US20210363245A1 (en) | Bicistronic chimeric antigen receptors targeting cd19 and cd20 and their uses | |
| JP2020517295A5 (enExample) | ||
| JP2018064568A (ja) | Ｐｄ−ｌ１によって誘導される免疫寛容の低減 | |
| JP2020022456A5 (enExample) | ||
| JP2017513478A5 (enExample) | ||
| US20200354451A1 (en) | Chimeric antigen receptors comprising a human transferrin epitope sequence | |
| CN105683214A (zh) | 触发针对多种肿瘤的抗体依赖细胞毒性的嵌合受体 | |
| WO2017176525A1 (en) | Car having replicated binding motifs in a co-stimulatory domain | |
| IL255697B2 (en) | Compositions and methods for TCR programming using fusion proteins | |
| JP2021500882A5 (enExample) | ||
| JP2017518071A5 (enExample) |